(IHE)

Let's delve into the ETF world following the 90-day U.S.-China trade deal.

Trump's plan to slash the price of prescription drugs by 30% put pharma ETFs in focus.

Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.

Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar...